nVerses Capital »

Indivior Pharmaceuticals shares owned by nVerses Capital

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $342k 11k 30.48

More positions owned by nVerses Capital

Lam Research Corp Com New (LRCX)
Ally Financial (ALLY)
Comfort Systems USA (FIX)
Intuitive Surgical Com New (ISRG)
Cintas Corporation (CTAS)
Owl Rock Capital Corporation (OBDC)
Stryker Corporation (SYK)
Jefferies Finl Group (JEF)
Atmus Filtration Technologies Ord (ATMU)
Tsakos Energy Navigation SHS (TEN)
Docusign (DOCU)
A10 Networks (ATEN)
Domino's Pizza (DPZ)
Arista Networks Com Shs (ANET)
Cincinnati Financial Corporation (CINF)

View all positions for nVerses Capital

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals